Dihydroartemisinin–piperaquine plus sulfadoxine–pyrimethamine versus either drug alone for intermittent preventive treatment of malaria in pregnancy: A double-blind, randomized, controlled phase 3 trial from Uganda
Authors
Peter Olwoch (ORCID: https://orcid.org/0000-0002-7396-3348)
National Institute of Allergy and Infectious Diseases
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Dihydroartemisinin–piperaquine plus sulfadoxine–pyrimethamine versus either drug alone for intermittent preventive treatment of malaria in pregnancy: A double-blind, randomized, controlled phase 3 trial from Uganda
Peter Olwoch, Miriam Nakalembe, Michelle E. Roh, Prasanna Jagannathan et al.
Citations
8 citations
Journal
PLoS Medicine
Topics
Malaria Research and Control
Field-Weighted Citation Impact (FWCI)
15.03
article
Dihydroartemisinin–piperaquine plus sulfadoxine–pyrimethamine versus either drug alone for intermittent preventive treatment of malaria in pregnancy: A double-blind, randomized, controlled phase 3 trial from Uganda
Peter Olwoch, Miriam Nakalembe, Michelle E. Roh, Prasanna Jagannathan, Grant Dorsey, Anju Ranjit, Tamara D. Clark, Joaniter I. Nankabirwa, Erin J. dela Cruz, Abel Kakuru, Harriet Adrama, Bishop Opira, Philip J. Rosenthal, John Ategeka, Nida Özarslan, Moses Robert Kamya, Jimmy Kizza, Miriam Aguti, Stephanie L. Gaw
article en
8 citations
Abstract
No abstract available for this paper.
Publication Tag
PLoS MedicineVol. 22(9)
Institutions
University of California, San Francisco (US), Busitema University (UG), Infectious Diseases Research Collaboration (UG), Global Brain Health Institute (US), Makerere University (UG), Stanford University (US)
Funders
National Institutes of Health, University of California, San Francisco, National Institute of Allergy and Infectious Diseases